Advertisement

Topics

TransEnterix, Stifel enter $50M equity offering sales deal

06:47 EDT 5 Sep 2017 | SmartBrief

An at-the-market equity offering sales agreement was reached by TransEnterix with Stifel, Nicolaus & Co.  -More

Original Article: TransEnterix, Stifel enter $50M equity offering sales deal

NEXT ARTICLE

More From BioPortfolio on "TransEnterix, Stifel enter $50M equity offering sales deal"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...